VERTEX PHARMACEUTICALS INC / MA Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2010 to Q3 2024.
  • Vertex Pharmaceuticals Inc / Ma Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 258M shares, unchanged year-over-year.
  • Vertex Pharmaceuticals Inc / Ma annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 258M shares, a 0.63% increase from 2022.
  • Vertex Pharmaceuticals Inc / Ma annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 256M shares, a 0.62% decline from 2021.
  • Vertex Pharmaceuticals Inc / Ma annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 258M shares, a 0.81% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 258M 0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 258M +400K +0.16% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 258M +800K +0.31% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 258M +1.6M +0.63% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 258M +1.5M +0.59% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 258M +1.8M +0.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 257M +2.3M +0.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 256M -1.6M -0.62% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 257M -1.4M -0.54% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 256M -3.1M -1.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 255M -4.3M -1.66% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 258M -2.34M -0.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 258M -2.49M -0.96% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 259M -637K -0.25% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 259M -415K -0.16% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 260M +2.04M +0.79% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-11
Q3 2020 260M +3.45M +1.34% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 260M +3.48M +1.36% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 260M +4.12M +1.61% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 258M +3.14M +1.23% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-11
Q3 2019 257M +2.04M +0.8% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-11
Q2 2019 256M +2.02M +0.79% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-11
Q1 2019 256M +2.46M +0.97% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-11
Q4 2018 255M +3.31M +1.32% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-13
Q3 2018 255M +4.64M +1.85% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-13
Q2 2018 254M +6.61M +2.67% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-13
Q1 2018 253M +7.21M +2.93% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-13
Q4 2017 252M +6.1M +2.49% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-13
Q3 2017 250M +5.35M +2.18% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-13
Q2 2017 248M +3.04M +1.24% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-13
Q1 2017 246M +2.19M +0.9% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-13
Q4 2016 245M +4.14M +1.72% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-15
Q3 2016 245M +2.95M +1.22% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-15
Q2 2016 244M +3.73M +1.55% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-15
Q1 2016 244M +4.34M +1.81% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-15
Q4 2015 241M +6.01M +2.55% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-15
Q3 2015 242M +5.83M +2.47% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-31
Q2 2015 241M +6.95M +2.97% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 239M +6.61M +2.84% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 235M +4.04M +1.75% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 236M +5.63M +2.44% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 234M +11.8M +5.29% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 233M +17.5M +8.11% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
Q4 2013 231M +16.7M +7.76% Oct 1, 2013 Dec 31, 2013 10-K 2014-02-11
Q3 2013 231M +16.7M +7.83% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 222M +10.7M +5.07% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 215M +7.4M +3.56% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q4 2012 215M +7.85M +3.8% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-11
Q3 2012 214M +7.77M +3.77% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-11
Q2 2012 211M +6.93M +3.39% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-11
Q1 2012 208M +5.69M +2.81% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-11
Q4 2011 207M +5.4M +2.68% Oct 1, 2011 Dec 31, 2011 10-K 2013-03-01
Q3 2011 206M +5.12M +2.55% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-01
Q2 2011 204M +4.02M +2% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-01
Q1 2011 202M +3.39M +1.71% Jan 1, 2011 Mar 31, 2011 10-K 2013-03-01
Q4 2010 201M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-22
Q3 2010 201M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-22
Q2 2010 200M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-22
Q1 2010 199M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.